Company intelligence / Profile preview

TALi Digital

Melbourne, Victoria, Australiatali.org ↗

Ownership: Private
Development stage: Commercial

Overview

TALi's digital therapeutics have demonstrated efficacy in improving cognitive function and behavior in children. Five clinical studies involving over 600 children showed improvements in cognitive abilities within one month of use. The company is pursuing FDA clearance for its products through a strategic partnership with Akili Interactive, which will commercialize the software if approved in the U.S.

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy (digital therapeutic software/games)
Industry: Digital Health Medical Devices

Partnerships

Akili Interactive (strategic licensing agreement for U.S. market development and commercialization)Invest Victoria grant support

Beyond the preview

Go deeper on TALi Digital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TALi Digital.

Explore the full profile